MX2009009934A - Inhibicion de la recaptacion de 4-[2-(4-metilfenilsulfanil)-fenil] piperidina combinada con serotina y norepinefrina para el tratamiento de adhd. melancolia depresion resistente al tratamiento o sintomas residuales en la depresion. - Google Patents
Inhibicion de la recaptacion de 4-[2-(4-metilfenilsulfanil)-fenil] piperidina combinada con serotina y norepinefrina para el tratamiento de adhd. melancolia depresion resistente al tratamiento o sintomas residuales en la depresion.Info
- Publication number
- MX2009009934A MX2009009934A MX2009009934A MX2009009934A MX2009009934A MX 2009009934 A MX2009009934 A MX 2009009934A MX 2009009934 A MX2009009934 A MX 2009009934A MX 2009009934 A MX2009009934 A MX 2009009934A MX 2009009934 A MX2009009934 A MX 2009009934A
- Authority
- MX
- Mexico
- Prior art keywords
- depression
- treatment
- melancholia
- adhd
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Se provee el uso de 4-[2-(4-metilfenilsulfanil)fenil]piperidina y sales de adición de ácidos de la misma para el tratamiento del ADHD, melancolía, depresión resistente al tratamiento o síntomas residuales en la depresión.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200700423 | 2007-03-20 | ||
PCT/DK2007/050076 WO2007144006A1 (en) | 2006-06-16 | 2007-06-15 | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
PCT/DK2008/050064 WO2008113360A2 (en) | 2007-03-20 | 2008-03-14 | 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009009934A true MX2009009934A (es) | 2009-09-24 |
Family
ID=39575680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009009934A MX2009009934A (es) | 2007-03-20 | 2008-03-14 | Inhibicion de la recaptacion de 4-[2-(4-metilfenilsulfanil)-fenil] piperidina combinada con serotina y norepinefrina para el tratamiento de adhd. melancolia depresion resistente al tratamiento o sintomas residuales en la depresion. |
Country Status (28)
Country | Link |
---|---|
US (2) | US20100144788A1 (es) |
EP (2) | EP2139479B1 (es) |
JP (1) | JP5388867B2 (es) |
KR (1) | KR20090125775A (es) |
CN (2) | CN101674830B (es) |
AR (1) | AR065798A1 (es) |
AU (1) | AU2008228639B2 (es) |
BR (1) | BRPI0808831A2 (es) |
CA (1) | CA2684556C (es) |
CL (1) | CL2008000796A1 (es) |
CO (1) | CO6220957A2 (es) |
CY (2) | CY1113965T1 (es) |
DK (2) | DK2139479T3 (es) |
EA (1) | EA017407B1 (es) |
ES (2) | ES2399305T3 (es) |
HK (1) | HK1142007A1 (es) |
HR (1) | HRP20130049T1 (es) |
IL (1) | IL200954A (es) |
MX (1) | MX2009009934A (es) |
MY (1) | MY163537A (es) |
NZ (1) | NZ579723A (es) |
PL (2) | PL2139479T3 (es) |
PT (2) | PT2139479E (es) |
RS (2) | RS52676B (es) |
SI (1) | SI2139479T1 (es) |
TW (1) | TWI432194B (es) |
UA (2) | UA97660C2 (es) |
WO (1) | WO2008113360A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5318757B2 (ja) * | 2006-06-16 | 2013-10-16 | ハー・ルンドベック・アクチエゼルスカベット | 神経因性疼痛の治療のための、組み合わされたセロトニンおよびノルエピネフリン再取り込み阻害を有する4−[2−(4−メチルフェニルスルファニル)−フェニル]ピペリジンの結晶形 |
TWI432194B (zh) | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | 4-〔2-(4-甲基苯硫基)苯基〕哌啶之新穎治療用途 |
SI2167085T1 (sl) * | 2007-06-15 | 2014-05-30 | H. Lundbeck A/S | 4-(2-(4-metilfenilsulfanil)fenil)piperidin za zdravljenje sindroma razdraĺ˝ljivega äśrevesja (ibs) |
TW200938194A (en) * | 2007-12-14 | 2009-09-16 | Lundbeck & Co As H | Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
RU2593771C2 (ru) * | 2010-04-30 | 2016-08-10 | Такеда Фармасьютикал Компани Лимитед | Энтеросолюбильная таблетка |
US8745134B1 (en) | 2011-03-04 | 2014-06-03 | Zynga Inc. | Cross social network data aggregation |
US8332488B1 (en) | 2011-03-04 | 2012-12-11 | Zynga Inc. | Multi-level cache with synch |
US8347322B1 (en) | 2011-03-31 | 2013-01-01 | Zynga Inc. | Social network application programming interface |
US10135776B1 (en) | 2011-03-31 | 2018-11-20 | Zynga Inc. | Cross platform social networking messaging system |
US8522137B1 (en) | 2011-06-30 | 2013-08-27 | Zynga Inc. | Systems, methods, and machine readable media for social network application development using a custom markup language |
BR112018003930A2 (pt) | 2016-07-01 | 2018-09-25 | H Lundbeck As | regimes de dosagem de vortioxetina para início rápido de efeito antidepressivo |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010043730A (ko) * | 1998-05-22 | 2001-05-25 | 피터 지. 스트링거 | 치료 불응성 우울증의 치료를 위한 조합 치료법 |
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
SI1626720T1 (sl) * | 2003-04-04 | 2008-12-31 | Lundbeck & Co As H | Derivati 4-(2-fenilsulfanil-fenil)-piperidina kotzaviralci ponovnega vnosa serotonina |
PT1635828E (pt) * | 2003-04-04 | 2008-07-01 | Lundbeck & Co As H | Derivados de 4-(2-feniloxifenil) piperidina ou de 1,2,3,6-tetrahidropiridina como inibidores da recaptação da serotonina |
AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
DE102006028034A1 (de) * | 2006-06-14 | 2007-12-20 | Leifheit Ag | Bürste und Kehrgerät mit Bürste |
JP5318757B2 (ja) * | 2006-06-16 | 2013-10-16 | ハー・ルンドベック・アクチエゼルスカベット | 神経因性疼痛の治療のための、組み合わされたセロトニンおよびノルエピネフリン再取り込み阻害を有する4−[2−(4−メチルフェニルスルファニル)−フェニル]ピペリジンの結晶形 |
TWI432194B (zh) | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | 4-〔2-(4-甲基苯硫基)苯基〕哌啶之新穎治療用途 |
TWI405588B (zh) | 2007-03-20 | 2013-08-21 | Lundbeck & Co As H | 4-〔2-(4-甲苯基硫基)-苯基〕哌啶之鹽類的液體調配物 |
TW200938194A (en) * | 2007-12-14 | 2009-09-16 | Lundbeck & Co As H | Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
-
2008
- 2008-03-07 TW TW097107980A patent/TWI432194B/zh not_active IP Right Cessation
- 2008-03-14 EA EA200970871A patent/EA017407B1/ru not_active IP Right Cessation
- 2008-03-14 RS RS20130046A patent/RS52676B/en unknown
- 2008-03-14 CN CN2008800085619A patent/CN101674830B/zh not_active Expired - Fee Related
- 2008-03-14 US US12/528,440 patent/US20100144788A1/en not_active Abandoned
- 2008-03-14 SI SI200830877T patent/SI2139479T1/sl unknown
- 2008-03-14 MX MX2009009934A patent/MX2009009934A/es active IP Right Grant
- 2008-03-14 PL PL08715618T patent/PL2139479T3/pl unknown
- 2008-03-14 MY MYPI20093674A patent/MY163537A/en unknown
- 2008-03-14 BR BRPI0808831-4A patent/BRPI0808831A2/pt not_active IP Right Cessation
- 2008-03-14 WO PCT/DK2008/050064 patent/WO2008113360A2/en active Application Filing
- 2008-03-14 UA UAA200910359A patent/UA97660C2/ru unknown
- 2008-03-14 UA UAA200910338A patent/UA99611C2/ru unknown
- 2008-03-14 NZ NZ579723A patent/NZ579723A/en not_active IP Right Cessation
- 2008-03-14 CA CA2684556A patent/CA2684556C/en not_active Expired - Fee Related
- 2008-03-14 PT PT87156188T patent/PT2139479E/pt unknown
- 2008-03-14 EP EP08715618A patent/EP2139479B1/en active Active
- 2008-03-14 CN CN2008800086715A patent/CN101646438B/zh not_active Expired - Fee Related
- 2008-03-14 KR KR1020097019599A patent/KR20090125775A/ko active IP Right Grant
- 2008-03-14 JP JP2009553911A patent/JP5388867B2/ja not_active Expired - Fee Related
- 2008-03-14 DK DK08715618.8T patent/DK2139479T3/da active
- 2008-03-14 AU AU2008228639A patent/AU2008228639B2/en not_active Ceased
- 2008-03-14 ES ES08715618T patent/ES2399305T3/es active Active
- 2008-03-19 CL CL200800796A patent/CL2008000796A1/es unknown
- 2008-03-19 AR ARP080101146A patent/AR065798A1/es unknown
- 2008-06-13 ES ES08758225.0T patent/ES2445400T3/es active Active
- 2008-06-13 PT PT87582250T patent/PT2167085E/pt unknown
- 2008-06-13 EP EP08758225.0A patent/EP2167085B1/en active Active
- 2008-06-13 PL PL08758225T patent/PL2167085T3/pl unknown
- 2008-06-13 US US12/600,884 patent/US8507526B2/en not_active Expired - Fee Related
- 2008-06-13 DK DK08758225.0T patent/DK2167085T3/da active
- 2008-06-13 RS RS20140029A patent/RS53138B/en unknown
-
2009
- 2009-09-15 IL IL200954A patent/IL200954A/en not_active IP Right Cessation
- 2009-09-15 CO CO09099807A patent/CO6220957A2/es not_active Application Discontinuation
-
2010
- 2010-09-10 HK HK10108625.4A patent/HK1142007A1/xx not_active IP Right Cessation
-
2013
- 2013-01-21 HR HRP20130049AT patent/HRP20130049T1/hr unknown
- 2013-02-15 CY CY20131100146T patent/CY1113965T1/el unknown
-
2014
- 2014-01-24 CY CY20141100065T patent/CY1114774T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009009934A (es) | Inhibicion de la recaptacion de 4-[2-(4-metilfenilsulfanil)-fenil] piperidina combinada con serotina y norepinefrina para el tratamiento de adhd. melancolia depresion resistente al tratamiento o sintomas residuales en la depresion. | |
UA97392C2 (ru) | 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазин как соединение с комбинированной активностью в отношении обратного захвата серотонина, 5-нт3 и 5-нт1a для лечения боли | |
NO20090250L (no) | Krystallinske former av 4-[2-(4-metylfenylsulfanyl)-fenyl]piperidin med kombinert serotonin- og norepinefrin reopptaksinhibering for behandlingen av nevropatisk smerte | |
MY150647A (en) | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment | |
CL2008002255A1 (es) | Compuesto 3-({4-(2,2-difluoroetil)-3-(1h-pirrolo [2,3-b] piridin-5-il)-1h-pirazol-4-il] pirimidin-2-il}amino)propanonitrilo, inhibidor de raf; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del crecimiento celular anormal o cualquier enfermedad o afeccion mediada por raf. | |
CL2011002697A1 (es) | Compuestos derivados de 3-[4-(oxo-dihidropiridin)bencil]-1,3-oxazin-ona hidratados, inhibidores 11beta-hsd1; composicion farmaceutica que los comprende; y su uso en el tratamiento de la diabetes | |
MY151211A (en) | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | |
PE20141120A1 (es) | Compuestos heterociclicos | |
RS50624B (sr) | Monohidrohloridna so 1-[3-[3-(4-hlorofenil)propoksi]propil]piperidina | |
NO20076680L (no) | Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter | |
NZ630488A (en) | Piperidine derivatives for gpr119 agonist | |
CL2007000595A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras. | |
AR077642A1 (es) | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo | |
PE20090320A1 (es) | Derivados de piperidina-amida | |
NZ586010A (en) | 4-[2-(4-Methylphenylsulfanyl)phenyl]piperidine for use in the treatment of depression associated with gastrointestinal pain such as irritable bowel syndrome | |
WO2009065921A3 (de) | Organischeverbindungen | |
MX2009009388A (es) | Formulaciones liquidas de sales de 4-[2-(4-metilfenilsulfanil)feni l]-piperidina. | |
MY150698A (en) | Crystalline forms of 4- [2- (-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
EA201000611A1 (ru) | 4,4-дизамещенные пиперидины | |
EA201000720A1 (ru) | 4,4-дизамещённые пиперидины как ингибиторы ренина | |
CL2008003036A1 (es) | Composicion farmaceutica acuosa que comprende 4-[(4-clorofenil)metil]-2-({(2r)-1-[4-(4-{[3-(hexahidro-1h-azepin-1-il)propil]oxi}fenil)butil]-2-pirrolidinil}metil)-1(2h)-ftalazinona; envase que la comprende; y uso para el tratamiento de enfermedades inflamatorias y/o alergicas tal como rinitis alergica. | |
TN2009000008A1 (en) | Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination | |
UA95801C2 (ru) | Кристаллические формы 4-[2-(4-метилфенилсульфанил)-фенил]пиперидина с комбинированным ингибированием обратного захвата серотонина и норэпинефрина для лечения невропатической боли | |
UY30770A1 (es) | Compuestos de piperidina, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
WO2007028812A3 (de) | Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |